Active ingredientForetinibCat. No. P-F113-001CAS 849217-64-7Family · Pharmaceutical analytical standards
Foretinib
An experimental inhibitor of the MET and VEGFR-2 tyrosine kinases, the receptors for the growth factors HGF and VEGF: it was studied against cancer in about ten phase II trials, but by 2015 its development appeared to have been discontinued. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Its structure is very similar to that of cabozantinib, another kinase inhibitor that did gain approval in the US: two near-twin molecules with different fates.
Go to the active ingredient →Active ingredientForetinibCat. No. P-F113-001CAS 849217-64-7
Isotopically labelledForetinib-13C,d3Cat. No. P-F113-003
ImpurityForetinib Impurity 1Cat. No. P-F113-004
ImpurityForetinib Impurity 2Cat. No. P-F113-005No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.